#biosimilarsindustry #biosimilars #NHS #longtermhealthconditions #healthandsocialcarespending #Chronicdiseases #BritishBiosimilarsAssociation #NHSreinvestment #NHSmedicinescosts #pharmaceuticalspending #biosimilarsadoption #VPAG #biosimilarmanufacturers #NHStenders #NHSresources
zurl.co/soiB5
zurl.co/soiB5
20-21 PHARMA - Same difference
-
magazine.pharmatimes.com
September 5, 2025 at 12:35 PM
It’s easy to forget the challenges #IBD patient’s face when it comes to the routine things in life we all have aspiration to work live provide for our families it’s not so easy with #Longtermhealthconditions
#Society makes it hard to function @bottomlineibd.bsky.social how can we help change this
#Society makes it hard to function @bottomlineibd.bsky.social how can we help change this
December 11, 2024 at 6:52 AM
It’s easy to forget the challenges #IBD patient’s face when it comes to the routine things in life we all have aspiration to work live provide for our families it’s not so easy with #Longtermhealthconditions
#Society makes it hard to function @bottomlineibd.bsky.social how can we help change this
#Society makes it hard to function @bottomlineibd.bsky.social how can we help change this
Such a shame the 'Westminster Powers' don't feel the same way Ed. It's clear those of us from the 'lower classes' especially those with #LongTermHealthConditions & or #Disabilities are not worth the extra £££ required to maintain a quality of Life.
November 29, 2024 at 1:38 PM
Such a shame the 'Westminster Powers' don't feel the same way Ed. It's clear those of us from the 'lower classes' especially those with #LongTermHealthConditions & or #Disabilities are not worth the extra £££ required to maintain a quality of Life.